Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function

Влияние ингибиторов SGLT2 на функцию почек и сердечно-сосудистой системы
Subodh Verma, Volker Vallon
2020-11-16

SGLT2 inhibitorsalbuminuriacardiorenal protectionglomerular hyperfiltrationtubular oxygenation
SGLT2 inhibitors are antihyperglycemic drugs that protect kidneys and the heart of patients with or without type 2 diabetes and preserved or reduced kidney function from failing. The involved protective mechanisms include blood glucose-dependent and -independent mechanisms: SGLT2 inhibitors prevent both hyper- and hypoglycemia, with expectedly little net effect on HbA1C. Metabolic adaptations to induced urinary glucose loss include reduced fat mass and more ketone bodies as additional fuel. SGLT2 inhibitors lower glomerular capillary hypertension and hyperfiltration, thereby reducing the physical stress on the filtration barrier, albuminuria, and the oxygen demand for tubular reabsorption. This improves cortical oxygenation, which, together with lesser tubular gluco-toxicity, may preserve tubular function and glomerular filtration rate in the long term. SGLT2 inhibitors may mimic systemic hypoxia and stimulate erythropoiesis, which improves organ oxygen delivery. SGLT2 inhibitors are proximal tubule and osmotic diuretics that reduce volume retention and blood pressure and preserve heart function, potentially in part by overcoming the resistance to diuretics and atrial-natriuretic-peptide and inhibiting Na-H exchangers and sympathetic tone.
1
As proximal-tubule and osmotic diuretics, SGLT2 inhibitors reduce volume retention and blood pressure and may preserve heart function by improving diuretic and natriuretic responses and lowering sympathetic tone.
2
By improving cortical oxygenation and reducing tubular glucotoxicity, SGLT2 inhibitors may preserve tubular function and long-term glomerular filtration rate.
3
Induced urinary glucose loss promotes reduced fat mass and increased ketone-body availability, while producing little net change in HbA1C and preventing both hyperglycemia and hypoglycemia.
4
SGLT2 inhibitors protect kidney and cardiovascular function in patients with or without type 2 diabetes and across preserved or reduced kidney function.
5
Their glucose-independent effects include reducing glomerular capillary hypertension, hyperfiltration, albuminuria, and tubular oxygen demand.

SGLT2 inhibitors in patients with or without type 2 diabetes and preserved or reduced kidney function

Kidney- and cardiovascular-protective mechanisms and effects, including changes in glomerular hemodynamics, tubular oxygenation, metabolism, erythropoiesis, fluid retention, blood pressure, and heart function

Publication Details
Publication Date
2020-11-16
Journal
Publisher
ISSN
Cited by
564
Access Type
Author Information
Authors
Subodh Verma
Volker Vallon
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%